spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  radiotherapeutic 

 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Nov 2023
Actinium Appoints Lynn Bodarky as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Feb 2023
Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Dec 2017
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA(R) (iobenguane I 131) in Pheochromocytoma and Paraganglioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Nov 2015
Spectrum Pharmaceuticals Divests Rights to ZEVALIN(R) (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2013
Novelos Therapeutics Announces a Restructuring of Its Board of Directors and Additional Changes to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2013
Novelos Appoints Industry Veteran to Lead Strategic Realignment
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jul 2013
Novelos Therapeutics Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2013
Novelos Therapeutics Provides Product Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jan 2013
Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five Years
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2012
Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012
Biopharmaceuticals Mergers & Acquisiitons
 HSMN NewsFeed - 16 Feb 2012
Radiosurgery Pioneer, University Hospital La Timone, Is World's First to Acquire Second Leksell Gamma Knife Perfexion
Devices Neurosurgery Oncology
 HSMN NewsFeed - 15 Dec 2011
RaySearch Laboratories: First European Patient Treated with RayStation(R)
Devices Oncology
 HSMN NewsFeed - 22 Mar 2011
FDA Accepts for Review Spectrum Pharmaceuticals’ ZEVALIN(R) Submission for the Removal of the Bioscan
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Nov 2009
Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2009
ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 14 May 2009
Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval to Proceed With Phase 3 Development of Onalta(TM)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 May 2009
Molecular Insight Pharmaceuticals Expands Management Team by Appointing Daniel L. Peters as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2009
Molecular Insight Receives Special Protocol Assessment Approval From FDA for Phase 2 Trial of Azedra(TM), a Radiotherapeutic to Treat Neuroendocrine Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
MDS Pharma Services Takes Novel Steps to Recruit Patients for Alzheimer’s Disease Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Sep 2008
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2008
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2008
MDS Pharma Services Names Teresa Winslow and James Miskel to Senior Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2007
Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2007
Molecular Insight Pharmaceuticals, Inc. Enters into Agreement to Purchase Radiopharmaceutical Manufacturing Facility
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2007
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra(TM) Therapeutic Trial in Neuroendocrine Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Brian Abeysekera, Ph.D., as Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2007
Molecular Insight Pharmaceuticals, Inc. Announces Initial Public Offering
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2007
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta(TM) (Formerly OctreoTher(TM))
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 17 Jan 2007
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate from Bayer Schering Pharma
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Oct 2006
RITA Medical Highlights Recent Clinical Publications Discussing Local Therapy Devices in the Treatment of Liver Tumors Associated With Colorectal Cancer
Devices Oncology
 HSMN NewsFeed - 1 Jun 2006
Avid RP Strengthens Its Drug and Business Development Capabilities with the Addition of Three Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
radiotherapeutic
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.